Cargando…
Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin
The aldehyde inhibitor Z-Ala-Ala-Phe-CHO has been synthesized and shown by (13)C-NMR to react with the active site serine hydroxyl group of alpha-chymotrypsin to form two diastereomeric hemiacetals. For both hemiacetals oxyanion formation occurs with a pK(a) value of ~ 7 showing that chymotrypsin re...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185751/ https://www.ncbi.nlm.nih.gov/pubmed/24657307 http://dx.doi.org/10.1016/j.bbapap.2014.03.008 |
_version_ | 1783526821425315840 |
---|---|
author | Cleary, Jennifer A. Doherty, William Evans, Paul Malthouse, J.Paul G. |
author_facet | Cleary, Jennifer A. Doherty, William Evans, Paul Malthouse, J.Paul G. |
author_sort | Cleary, Jennifer A. |
collection | PubMed |
description | The aldehyde inhibitor Z-Ala-Ala-Phe-CHO has been synthesized and shown by (13)C-NMR to react with the active site serine hydroxyl group of alpha-chymotrypsin to form two diastereomeric hemiacetals. For both hemiacetals oxyanion formation occurs with a pK(a) value of ~ 7 showing that chymotrypsin reduces the oxyanion pK(a) values by ~ 5.6 pK(a) units and stabilizes the oxyanions of both diastereoisomers by ~ 32 kJ mol(− 1). As pH has only a small effect on binding we conclude that oxyanion formation does not have a significant effect on binding the aldehyde inhibitor. By comparing the binding of Z-Ala-Ala-Phe-CHO with that of Z-Ala-Ala-Phe-H we estimate that the aldehyde group increases binding ~ 100 fold. At pH 7.2 the effective molarity of the active site serine hydroxy group is ~ 6000 which is ~ 7 × less effective than with the corresponding glyoxal inhibitor. Using (1)H-NMR we have shown that at both 4 and 25 °C the histidine pK(a) is ~ 7.3 in free chymotrypsin and it is raised to ~ 8 when Z-Ala-Ala-Phe-CHO is bound. We conclude that oxyanion formation only has a minor role in raising the histidine pK(a) and that the aldehyde hydrogen must be replaced by a larger group to raise the histidine pK(a) > 10 and give stereospecific formation of tetrahedral intermediates. The results show that a large increase in the pK(a) of the active site histidine is not needed for the active site serine hydroxyl group to have an effective molarity of 6000. |
format | Online Article Text |
id | pubmed-7185751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71857512020-04-28 Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin Cleary, Jennifer A. Doherty, William Evans, Paul Malthouse, J.Paul G. Biochim Biophys Acta Proteins Proteom Article The aldehyde inhibitor Z-Ala-Ala-Phe-CHO has been synthesized and shown by (13)C-NMR to react with the active site serine hydroxyl group of alpha-chymotrypsin to form two diastereomeric hemiacetals. For both hemiacetals oxyanion formation occurs with a pK(a) value of ~ 7 showing that chymotrypsin reduces the oxyanion pK(a) values by ~ 5.6 pK(a) units and stabilizes the oxyanions of both diastereoisomers by ~ 32 kJ mol(− 1). As pH has only a small effect on binding we conclude that oxyanion formation does not have a significant effect on binding the aldehyde inhibitor. By comparing the binding of Z-Ala-Ala-Phe-CHO with that of Z-Ala-Ala-Phe-H we estimate that the aldehyde group increases binding ~ 100 fold. At pH 7.2 the effective molarity of the active site serine hydroxy group is ~ 6000 which is ~ 7 × less effective than with the corresponding glyoxal inhibitor. Using (1)H-NMR we have shown that at both 4 and 25 °C the histidine pK(a) is ~ 7.3 in free chymotrypsin and it is raised to ~ 8 when Z-Ala-Ala-Phe-CHO is bound. We conclude that oxyanion formation only has a minor role in raising the histidine pK(a) and that the aldehyde hydrogen must be replaced by a larger group to raise the histidine pK(a) > 10 and give stereospecific formation of tetrahedral intermediates. The results show that a large increase in the pK(a) of the active site histidine is not needed for the active site serine hydroxyl group to have an effective molarity of 6000. Elsevier B.V. 2014-06 2014-03-21 /pmc/articles/PMC7185751/ /pubmed/24657307 http://dx.doi.org/10.1016/j.bbapap.2014.03.008 Text en Copyright © 2014 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Cleary, Jennifer A. Doherty, William Evans, Paul Malthouse, J.Paul G. Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin |
title | Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin |
title_full | Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin |
title_fullStr | Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin |
title_full_unstemmed | Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin |
title_short | Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin |
title_sort | hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185751/ https://www.ncbi.nlm.nih.gov/pubmed/24657307 http://dx.doi.org/10.1016/j.bbapap.2014.03.008 |
work_keys_str_mv | AT clearyjennifera hemiacetalstabilizationinachymotrypsininhibitorcomplexandthereactivityofthehydroxylgroupofthecatalyticserineresidueofchymotrypsin AT dohertywilliam hemiacetalstabilizationinachymotrypsininhibitorcomplexandthereactivityofthehydroxylgroupofthecatalyticserineresidueofchymotrypsin AT evanspaul hemiacetalstabilizationinachymotrypsininhibitorcomplexandthereactivityofthehydroxylgroupofthecatalyticserineresidueofchymotrypsin AT malthousejpaulg hemiacetalstabilizationinachymotrypsininhibitorcomplexandthereactivityofthehydroxylgroupofthecatalyticserineresidueofchymotrypsin |